-
公开(公告)号:US12076400B2
公开(公告)日:2024-09-03
申请号:US16887460
申请日:2020-05-29
IPC分类号: A61K39/395 , A61K31/519 , A61K31/7068 , A61K33/243 , A61K47/68
CPC分类号: A61K39/3955 , A61K31/519 , A61K31/7068 , A61K33/243 , A61K47/6817
摘要: Described herein is a method of treating breast cancer comprising administering a bispecific antigen-binding construct targeting HER2 or a bispecific antigen-binding construct targeting HER2 linked to an auristatin analogue (ADC) in combination with a CDK4/6 inhibitor to a subject.